138 related articles for article (PubMed ID: 18496130)
1. Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia.
Kamdem LK; Hamilton L; Cheng C; Liu W; Yang W; Johnson JA; Pui CH; Relling MV
Pharmacogenet Genomics; 2008 Jun; 18(6):507-14. PubMed ID: 18496130
[TBL] [Abstract][Full Text] [Related]
2. Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia.
Kishi S; Yang W; Boureau B; Morand S; Das S; Chen P; Cook EH; Rosner GL; Schuetz E; Pui CH; Relling MV
Blood; 2004 Jan; 103(1):67-72. PubMed ID: 12969965
[TBL] [Abstract][Full Text] [Related]
3. The impact of CYP3A5*3 on risk and prognosis in childhood acute lymphoblastic leukemia.
Borst L; Wallerek S; Dalhoff K; Rasmussen KK; Wesenberg F; Wehner PS; Schmiegelow K
Eur J Haematol; 2011 Jun; 86(6):477-83. PubMed ID: 21418106
[TBL] [Abstract][Full Text] [Related]
4. Response to glucocorticoids and toxicity in childhood acute lymphoblastic leukemia: role of polymorphisms of genes involved in glucocorticoid response.
Marino S; Verzegnassi F; Tamaro P; Stocco G; Bartoli F; Decorti G; Rabusin M
Pediatr Blood Cancer; 2009 Dec; 53(6):984-91. PubMed ID: 19621425
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in CYP3A5, CYP3A4 and NQO1 in children who developed therapy-related myeloid malignancies.
Blanco JG; Edick MJ; Hancock ML; Winick NJ; Dervieux T; Amylon MD; Bash RO; Behm FG; Camitta BM; Pui CH; Raimondi SC; Relling MV
Pharmacogenetics; 2002 Nov; 12(8):605-11. PubMed ID: 12439220
[TBL] [Abstract][Full Text] [Related]
6. Effects of cytochrome P450 family 3 subfamily A member 5 gene polymorphisms on daunorubicin metabolism and adverse reactions in patients with acute leukemia.
Huang Z; Wang J; Qian J; Li Y; Xu Z; Chen M; Tong H
Mol Med Rep; 2017 Jun; 15(6):3493-3498. PubMed ID: 28440407
[TBL] [Abstract][Full Text] [Related]
7. The influence of polymorphisms in the drug transporter, ABCB1 on the toxicity of glucocorticoids in Saudi children with acute lymphoblastic leukaemia.
ElFayoumi RI; Hagras MM; Abozenadaha A; Gari M; Abosoudah I; Shinawi T; Mirza T; Bawazir W
Pharmacol Rep; 2019 Feb; 71(1):90-95. PubMed ID: 30508724
[TBL] [Abstract][Full Text] [Related]
8. A
Zgheib NK; El-Khoury H; Maamari D; Basbous M; Saab R; Muwakkit SA
Per Med; 2021 Sep; 18(5):431-439. PubMed ID: 34406079
[TBL] [Abstract][Full Text] [Related]
9. Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia.
Tissing WJ; Meijerink JP; den Boer ML; Brinkhof B; van Rossum EF; van Wering ER; Koper JW; Sonneveld P; Pieters R
Clin Cancer Res; 2005 Aug; 11(16):6050-6. PubMed ID: 16115950
[TBL] [Abstract][Full Text] [Related]
10. Impact of CYP1A1, GSTP1 and XRCC1 genes polymorphisms on toxicity and response to chemotherapy in childhood acute lymphoblastic leukemia.
Abo-Bakr A; Mossallam G; El Azhary N; Hafez H; Badawy R
J Egypt Natl Canc Inst; 2017 Sep; 29(3):127-133. PubMed ID: 28844589
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia.
Anderer G; Schrappe M; Brechlin AM; Lauten M; Muti P; Welte K; Stanulla M
Pharmacogenetics; 2000 Nov; 10(8):715-26. PubMed ID: 11186134
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemia.
Hartman A; van Schaik RH; van der Heiden IP; Broekhuis MJ; Meier M; den Boer ML; Pieters R
Leuk Res; 2010 Feb; 34(2):154-9. PubMed ID: 19467705
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in genes involved in the corticosteroid response and the outcome of childhood acute lymphoblastic leukemia.
Fleury I; Primeau M; Doreau A; Costea I; Moghrabi A; Sinnett D; Krajinovic M
Am J Pharmacogenomics; 2004; 4(5):331-41. PubMed ID: 15462611
[TBL] [Abstract][Full Text] [Related]
15. Association Between NR3C1 Gene Polymorphisms and Toxicity Induced by Glucocorticoids Therapy in Saudi Children with Acute Lymphoblastic Leukemia.
El-Fayoumi R; Hagras M; Abozenadaha A; Bawazir W; Shinawi T
Asian Pac J Cancer Prev; 2018 May; 19(5):1415-1423. PubMed ID: 29802709
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.
Rocha JC; Cheng C; Liu W; Kishi S; Das S; Cook EH; Sandlund JT; Rubnitz J; Ribeiro R; Campana D; Pui CH; Evans WE; Relling MV
Blood; 2005 Jun; 105(12):4752-8. PubMed ID: 15713801
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.
Yang JJ; Cheng C; Yang W; Pei D; Cao X; Fan Y; Pounds SB; Neale G; Treviño LR; French D; Campana D; Downing JR; Evans WE; Pui CH; Devidas M; Bowman WP; Camitta BM; Willman CL; Davies SM; Borowitz MJ; Carroll WL; Hunger SP; Relling MV
JAMA; 2009 Jan; 301(4):393-403. PubMed ID: 19176441
[TBL] [Abstract][Full Text] [Related]
18. Possible roles of genetic variations in chemotherapy related cardiotoxicity in pediatric acute lymphoblastic leukemia and osteosarcoma.
Sági JC; Egyed B; Kelemen A; Kutszegi N; Hegyi M; Gézsi A; Herlitschke MA; Rzepiel A; Fodor LE; Ottóffy G; Kovács GT; Erdélyi DJ; Szalai C; Semsei ÁF
BMC Cancer; 2018 Jul; 18(1):704. PubMed ID: 29970035
[TBL] [Abstract][Full Text] [Related]
19. The glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapy.
Eipel OT; Németh K; Török D; Csordás K; Hegyi M; Ponyi A; Ferenczy A; Erdélyi DJ; Csóka M; Kovács GT
Int J Hematol; 2013 Feb; 97(2):216-22. PubMed ID: 23355259
[TBL] [Abstract][Full Text] [Related]
20. The effect of race on the CYP3A-mediated metabolism of vincristine in pediatric patients with acute lymphoblastic leukemia.
Sims RP
J Oncol Pharm Pract; 2016 Feb; 22(1):76-81. PubMed ID: 25305360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]